Literature DB >> 27825034

Influenza A virus hemagglutinin specific antibodies interfere with virion neuraminidase activity via two distinct mechanisms.

Ivan Kosik1, Jonathan W Yewdell1.   

Abstract

We studied the ability of monoclonal Abs (mAbs) recognizing the major hemagglutinin (HA) antigenic sites to inhibit neuraminidase (NA) cleavage of sialic acids on fetuin. We show that virion associated-NA activity in the enzyme linked lectin assay (ELLA) is largely dependent on HA-mediated attachment of virions to immobilized fetuin. For a Sb-antigenic site specific mAb, there is a nearly perfect correlation between neuraminidase inhibition and blocking virus attachment to immobilized fetuin. By contrast, Sa-, Ca-, and Cb- antigenic site specific mAbs block NA activity in ELLA or the traditional thiobarbituric acid assay by sterically interfering with NA access to substrate. We conclude first, that ELLA with intact virus can only be used to measure anti-NA Abs if sera lack HA-specific Abs, and second, that anti-HA Abs block NA activity by both limiting virion interaction with sialic acid containing surfaces and by sterically limiting NA access to sialic acids attached to macromolecules. Published by Elsevier Inc.

Entities:  

Keywords:  Canonical antigenic sites; ELLA; HA antibodies; Influenza; NA inhibition; TBAA

Mesh:

Substances:

Year:  2016        PMID: 27825034      PMCID: PMC5127735          DOI: 10.1016/j.virol.2016.10.024

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  22 in total

1.  Changes in the haemagglutinin and the neuraminidase genes prior to the emergence of highly pathogenic H7N1 avian influenza viruses in Italy.

Authors:  J Banks; E S Speidel; E Moore; L Plowright; A Piccirillo; I Capua; P Cordioli; A Fioretti; D J Alexander
Journal:  Arch Virol       Date:  2001       Impact factor: 2.574

2.  Characterization of temperature sensitive influenza virus mutants defective in neuraminidase.

Authors:  P Palese; K Tobita; M Ueda; R W Compans
Journal:  Virology       Date:  1974-10       Impact factor: 3.616

3.  Serological relationships between the neuraminidases in influenza viruses.

Authors:  C K Paniker
Journal:  J Gen Virol       Date:  1968-05       Impact factor: 3.891

4.  The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype).

Authors:  A J Caton; G G Brownlee; J W Yewdell; W Gerhard
Journal:  Cell       Date:  1982-12       Impact factor: 41.582

5.  Balanced hemagglutinin and neuraminidase activities are critical for efficient replication of influenza A virus.

Authors:  L J Mitnaul; M N Matrosovich; M R Castrucci; A B Tuzikov; N V Bovin; D Kobasa; Y Kawaoka
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

6.  Antigenic structure of influenza virus haemagglutinin defined by hybridoma antibodies.

Authors:  W Gerhard; J Yewdell; M E Frankel; R Webster
Journal:  Nature       Date:  1981-04-23       Impact factor: 49.962

7.  Effects of single-point amino acid substitutions on the structure and function neuraminidase proteins in influenza A virus.

Authors:  Takuya Yano; Eri Nobusawa; Alexander Nagy; Setsuko Nakajima; Katsuhisa Nakajima
Journal:  Microbiol Immunol       Date:  2008-04       Impact factor: 1.955

8.  Antiviral activity of antiserum specific for an influenza virus neuraminidase.

Authors:  E D Kilbourne; W G Laver; J L Schulman; R G Webster
Journal:  J Virol       Date:  1968-04       Impact factor: 5.103

9.  Influenza A virus hemagglutinin antibody escape promotes neuraminidase antigenic variation and drug resistance.

Authors:  Scott E Hensley; Suman R Das; James S Gibbs; Adam L Bailey; Loren M Schmidt; Jack R Bennink; Jonathan W Yewdell
Journal:  PLoS One       Date:  2011-02-22       Impact factor: 3.240

10.  Conserved and host-specific features of influenza virion architecture.

Authors:  Edward C Hutchinson; Philip D Charles; Svenja S Hester; Benjamin Thomas; David Trudgian; Mónica Martínez-Alonso; Ervin Fodor
Journal:  Nat Commun       Date:  2014-09-16       Impact factor: 14.919

View more
  18 in total

1.  Hemagglutinin Stalk-Reactive Antibodies Interfere with Influenza Virus Neuraminidase Activity by Steric Hindrance.

Authors:  Yao-Qing Chen; Linda Yu-Ling Lan; Min Huang; Carole Henry; Patrick C Wilson
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

2.  Influenza-infected newborn and adult monkeys exhibit a strong primary antibody response to hemagglutinin stem.

Authors:  Elene Clemens; Davide Angeletti; Beth C Holbrook; Masaru Kanekiyo; Matthew J Jorgensen; Barney S Graham; Jonathan Yewdell; Martha A Alexander-Miller
Journal:  JCI Insight       Date:  2020-03-12

3.  Neuraminidase, the Forgotten Surface Antigen, Emerges as an Influenza Vaccine Target for Broadened Protection.

Authors:  Maryna C Eichelberger; Arnold S Monto
Journal:  J Infect Dis       Date:  2019-04-08       Impact factor: 5.226

Review 4.  Neuraminidase as an influenza vaccine antigen: a low hanging fruit, ready for picking to improve vaccine effectiveness.

Authors:  Maryna C Eichelberger; David M Morens; Jeffery K Taubenberger
Journal:  Curr Opin Immunol       Date:  2018-04-16       Impact factor: 7.486

Review 5.  Development of a Universal Influenza Vaccine.

Authors:  Leonardo D Estrada; Stacey Schultz-Cherry
Journal:  J Immunol       Date:  2019-01-15       Impact factor: 5.422

Review 6.  Antibody Immunodominance: The Key to Understanding Influenza Virus Antigenic Drift.

Authors:  Meghan O Altman; Davide Angeletti; Jonathan W Yewdell
Journal:  Viral Immunol       Date:  2018-01-22       Impact factor: 2.257

7.  Validation of a Harmonized Enzyme-Linked-Lectin-Assay (ELLA-NI) Based Neuraminidase Inhibition Assay Standard Operating Procedure (SOP) for Quantification of N1 Influenza Antibodies and the Use of a Calibrator to Improve the Reproducibility of the ELLA-NI With Reverse Genetics Viral and Recombinant Neuraminidase Antigens: A FLUCOP Collaborative Study.

Authors:  Marie-Clotilde Bernard; Joanna Waldock; Sylvie Commandeur; Lea Strauß; Claudia Maria Trombetta; Serena Marchi; Fan Zhou; Serge van de Witte; Peter van Amsterdam; Sammy Ho; Katja Hoschler; Vladimir Lugovtsev; Jerry P Weir; Emanuele Montomoli; Rebecca J Cox; Othmar G Engelhardt; Damien Friel; Ralf Wagner; Thierry Ollinger; Sophie Germain; Hanna Sediri-Schön
Journal:  Front Immunol       Date:  2022-06-17       Impact factor: 8.786

8.  Antigenic comparison of the neuraminidases from recent influenza A vaccine viruses and 2019-2020 circulating strains.

Authors:  Jin Gao; Xing Li; Laura Klenow; Tahir Malik; Hongquan Wan; Zhiping Ye; Robert Daniels
Journal:  NPJ Vaccines       Date:  2022-07-14       Impact factor: 9.399

9.  Influenza hemagglutinin-specific IgA Fc-effector functionality is restricted to stalk epitopes.

Authors:  Alec W Freyn; Julianna Han; Jenna J Guthmiller; Mark J Bailey; Karlynn Neu; Hannah L Turner; Victoria C Rosado; Veronika Chromikova; Min Huang; Shirin Strohmeier; Sean T H Liu; Viviana Simon; Florian Krammer; Andrew B Ward; Peter Palese; Patrick C Wilson; Raffael Nachbagauer
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-23       Impact factor: 11.205

10.  Universal Influenza Virus Neuraminidase Vaccine Elicits Protective Immune Responses against Human Seasonal and Pre-pandemic Strains.

Authors:  Amanda L Skarlupka; Anne-Gaelle Bebin-Blackwell; Spencer F Sumner; Ted M Ross
Journal:  J Virol       Date:  2021-08-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.